Inhibition of the Tumor-Promoting Action of 12-O-Tetradecanoylphorbol-13-Acetate by some Oleanane-Type Triterpenoid Compounds

ISSN: 15387445
204Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Since glycyrrhetinic acid was proved to suppress tumor promoter effects, several oleanane-type triterpenes which were chemically derived from oleanolic acid and hederagenin were tested in vitro and in vivo against the action of tumor promoter, 12-0-tetradecanoylphorbol 13-acetate. By in vitro experiment monitoring with 12-0-tetradecanoylphorbol-13-acetate-induced stimulation of 32Pi incorporation into phospholipids and an in vivo test on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene and promoted with 12-0-tetradecanoylphorhol-13-acetate, 18β-olean-l 2-ene-3β,28-diol (=erythrodiol), 18β-olean-12-ene-3β,23,28-triol, 18α-olean-l 2-ene-3β,28-diol, and 18α-olean-12-ene-3β,23,28-triol showed remarkable suppressive effects. Especially 18α-oleanane derivatives having a CH2OH grouping converted from the COOH group initially allocated at C-17 were 100 times more effective than glycyrrhetinic acid both in vitro and in vivo. © 1988, American Association for Cancer Research. All rights reserved.

Cite

CITATION STYLE

APA

Nishino, H., Nishino, A., Takayasu, J., Hasegawa, T., Iwashima, A., Hirabayashi, K., … Shibata, S. (1988). Inhibition of the Tumor-Promoting Action of 12-O-Tetradecanoylphorbol-13-Acetate by some Oleanane-Type Triterpenoid Compounds. Cancer Research, 48(18), 5210–5215.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free